Multiple Sclerosis

MS Drugs reduce inflammation, helping reduce relapses and slow disease progression

Disease-Modifying Drugs calm the body's inflammatory response to help stave off relapses—when new or existing MS symptoms show up for a day or longer. Avoiding smoking, exercising, reducing stress via mindfulness, checking for vitamin D deficiencies, drinking more water and eating well, all can slow disease progression. [The jury's still out on if HRT around the time of menopause may reduce dementia risk](https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(25)00122-9/fulltext) Estrogen can reduce inflammation and support neural growth in the brain, and some research has suggested that beginning hormone replacement therapy around menopause—versus later in life—reduces Alzheimer's disease risk. Still, a recent systematic review concluded that taking HRT didn't affect dementia risk, regardless of when women started taking it, so the science remains unsettled.

There are multiple types of multiple sclerosis—they differ by attack patterns

When your immune system targets the nervous system, this can cause new or worsening symptoms and the development of scarring or damage within the central nervous system. Relapsing-remitting MS is the most common type of the disease—it includes progressive bouts of attacks that occur months or years apart.

MS can damage the brain up to 7 years before symptoms appear

Recent research scouring blood samples from 134 people with MS, both before and after their diagnosis, found that about seven years before these patients were diagnosed, there was a spike in a protein called myelin oligodendrocyte glycoprotein—indicating disease-associated damage to the protective myelin around nerve fibers.

Epstein-Barr virus—the cause of 'kissing disease' mononucleosis—may be the leading cause of MS

A Harvard study with data from more than 10 million US military personnel found that people that contracted Epstein-Barr virus had a roughly 32-fold increased risk of developing multiple sclerosis. The work, published in 2022, found that Infection of the virus preceded MS onset by a median of five years, raising questions about better Epstein-Barr virus management and potential disease prevention.

A vaccine against Epstein-Barr virus, researchers hypothesize, could potentially prevent MS

As many as a quarter of MS patients have antibodies in their blood that bind to both a central protein in Epstein-Barr virus and a protein made in the brain and spinal cord that—when attacked—leads to a breakdown of protective nerve fiber insulation. This suggests the immune system's primed to attack the nervous system after mounting a defense against Epstein-Barr.

Females are diagnosed with MS roughly 3 to 4 times more often than males

This PBS documentary traces a filmmaker's personal journey with MS after being diagnosed at age 26. It encompasses both his efforts to stymie the disease's progression and his search for answers about the disease, when, statistically, he seemed at low risk due to his gender, lack of known family risk, and other factors.

MS disproportionately sickens women, but men tend to have worse outcomes

Though the disease is more common in women, men's symptoms progress more quickly, with men more often diagnosed with progressive MS and men's cases typically resulting in more severe symptoms—perhaps due at least partly to more delayed diagnosis—and more severe disability over time.

MS risk is shaped by geography, not just genes

Latitude—and related vitamin D exposure—seems to affect MS risk. People who migrate from a high-risk MS latitude (like northern Europe or the northern US) to a lower-risk latitude (like tropical areas) before age 15 tend to adopt the lower risk of their new country—suggesting there's a critical window for environmental exposure.

Cigarette smoke exposure boosts MS risk by up to 55%, though smokeless tobacco doesn't

The components of the smoke itself are associated with these significantly increased risks, so it's something beyond nicotine itself that drives that risk. What's more, smoking also increases the risk of developing antibodies to MS-treating drugs.

Lack of Vitamin D seems to be one major factor fueling MS risk

Researchers believe that a combination of factors can elevate MS risk, including a lack of vitamin D exposure in different locales, genetic history, cigarette smoke exposure, and Epstein-Barr virus infection.